Ifg Advisory, LLC Biogen Inc. Transaction History

Ifg Advisory, LLC

$1.54 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$190.52 - $236.72 $287,685 - $357,447	1,510 New	1,510 $350,000
Q4 2023 Jan 17, 2024	BUY	$222.59 - $267.94 $20,700 - $24,918	93 Added 5.52%	1,779 $460,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $427,063 - $482,010	1,686 New	1,686 $433,000
Q1 2023 Apr 26, 2023	SELL	$256.56 - $292.34 $9,749 - $11,108	-38 Reduced 2.2%	1,686 $468,000
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $335,645 - $462,825	1,724 New	1,724 $460,000
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $210,046 - $264,647	-1,084 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$259.0 - $414.71 $12,432 - $19,906	-48 Reduced 4.24%	1,084 $375,000
Q1 2021 Apr 19, 2021	SELL	$242.95 - $284.63 $8,989 - $10,531	-37 Reduced 3.17%	1,132 $316,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $29,059 - $43,742	-123 Reduced 9.52%	1,169 $286,000
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $79,431 - $91,713	300 Added 30.24%	1,292 $366,000
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $4,397 - $5,823	-17 Reduced 1.68%	992 $265,000
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $11,829 - $15,005	44 Added 4.56%	1,009 $319,000
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $15,844 - $21,893	-72 Reduced 6.94%	965 $286,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $394,871 - $442,886	-1,816 Reduced 63.65%	1,037 $241,000
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $12,280 - $13,536	-56 Reduced 1.93%	2,853 $667,000
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $70,864 - $110,839	-327 Reduced 10.11%	2,909 $687,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $36,483 - $46,210	131 Added 4.22%	3,236 $973,000
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $16,730 - $21,878	57 Added 1.87%	3,105 $1.1 Million
Q2 2018 Aug 02, 2018	BUY	$257.52 - $306.91 $18,026 - $21,483	70 Added 2.35%	3,048 $884,000
Q1 2018 Apr 26, 2018	SELL	$260.13 - $367.91 $40,840 - $57,761	-157 Reduced 5.01%	2,978 $0
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $4.56 Million - $5.11 Million	-14,835 Reduced 82.55%	3,135 $998,000
Q4 2017 Jan 29, 2018	BUY	$307.64 - $344.58 $5.53 Million - $6.19 Million	17,970	17,970 $1.04 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.49 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.43 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.17 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.09 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$765 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account